Genmab — Maj 2020

[Sukkeralf]

Ja godt for ofa og dara

[bibob]

5 C25 aktier over 60 % på styrkebarometer. ØU. https://ugebrev.dk/flashnews/investering/fem-c25-over-60-paa-styrkebarometer-staerkest-er-pandora-71/

[Bulder]

Looks like NCCN guidelines also covers dara in frontline transplant setting, which is not included in the approval message. I have a Q for Winkel about that just to be sure.

[E_L]

good idea!

[E_L]

@bongobob was it not possible to find an easier article to post on a monday morning?? I am wondering if it has anyting to do with Covid-1 research , also since they work together with the Dutch blood bank?

[bongobob]

It’s fascinating to see scientists in action and how they stand on each others shoulders. Like this:” The infants of mothers carrying this IgG3 polymorphic variant were found to have an increased protection against malaria, most likely caused by the malaria specific IgG3 antibodies crossing the placental membrane more efficiently as a result of increased binding to FcRn”

[bongobob]

Fun ain't it

[E_L]

[Sukkeralf]

Er der nok spørgsmål Helge

[Helge_LarsenPI-redaktør]

Et par enkelte mere er der plads til.

[peter12]

EL@ NCCN guidelines from 8 May. Isn't it the compendia listing we are talking about ??

[E_L]

yes, i think it could be, would be nice if Jan could confirm this afternoon

[Bulder]

I think the connection between listing and guidelines is that if a drug is on the compendia listing it can be used off line. If it is in the guidelines it can be used in a way described in the guidelines.

[Bulder]

off line = off label

[GeorgeBest]

AlphaValue raises target price on Genmab
to 1902, but keeps reduce rating

[Bulder]

So according to Landgren guidelines say ok to sc in all indications.

[Helge_LarsenPI-redaktør]

10 minutter til Q&A.

[E_L]

I did not realise Genmab could up the stakes in Camidanlumab. nice option

[henrik48]

Tusind tak til kompetente spørgere og moderator for en glimrende Q&A

[Sukkeralf]

I thought they have rejected that option a while ago